Bodal Chemicals Q1 FY27: Revenue Jumps 56 Percent as Integration and Pricing Power Show Through

Bodal Chemicals opened FY27 with a sharp step up in scale. In Q1 FY27, consolidated revenue rose to Rs 7,152 million, up 56.1 percent year on year, while EBITDA increased 45.4 percent to Rs 751 million. Profit after tax expanded even faster to Rs 303.8 million versus Rs 95.3 million a year ago, taking PAT margin to 4.2 percent from 2.1 percent.

The quarter mattered because the driver was not a one off gain. Management linked the performance to a familiar chemical cycle factor, raw material inflation tied to crude oil, and to something more structural, the company’s integrated manufacturing model. With major raw materials linked to crude, the quarter saw higher input costs. Bodal reported that demand conditions were supportive enough to pass through the higher cost in finished goods. That pass through, combined with a cascading benefit across Basic Chemicals, Dye Intermediates, and Dyestuffs, lifted realizations and helped convert revenue growth into profit growth. The Saykha benzene downstream division also began contributing to the topline during the quarter, adding an early incremental lever to the mix.

What drove the quarter: pass through, better realizations, and new contribution

Bodal’s segment commentary explains why the headline growth did not come only from volume expansion. Dye Intermediates revenue rose 44 percent year on year to Rs 2,166 million, supported by improved realization and volume. Dyestuffs revenue grew 23 percent to Rs 1,490 million, with better realization helping absorb raw material pressure. Basic Chemicals revenue almost doubled to Rs 839 million, up 89 percent year on year, which management linked mainly to an increase in sulphur, its main raw material. Chlor Alkali was steadier, with revenue of Rs 870 million, up 3 percent year on year.

There were also early signs that the portfolio is widening. The benzene downstream products division at Saykha started contributing in Q1 FY27, and the company expects gradual revenue growth with meaningful quarter on quarter contribution. That expectation is important because it frames FY27 as not just a recovery in legacy dye chain economics, but also a year where a newer stream begins to scale.

Subsidiary performance was mixed but directionally improved in key areas. Sen-er Boya, the Turkish subsidiary, reported 41 percent growth in revenue and PAT of Rs 22 million in Q1 FY27. Bodal Chemicals Trading Private Limited reported satisfactory performance, while the China and Indonesia subsidiaries remained subdued during the quarter.

Segment picture: revenue surged even as some volumes softened

A closer look at Q1 FY27 shows an important nuance. Revenue growth came alongside a mixed production volume trend on the standalone basis. Basic Chemicals production volume declined to 54,969 MT from 56,731 MT in Q1 FY26. Chlor Alkali caustic soda volume also reduced to 18,763 MT from 20,557 MT. Meanwhile, Dye Intermediates volume increased meaningfully to 8,126 MT from 6,892 MT, and Dyestuffs volume was flat at 3,742 MT.

This pattern supports management’s emphasis on realizations and integration. If some large commodity linked volumes are lower while revenue is sharply higher, it suggests price increases and product mix are doing much of the work. It also aligns with the company’s view that higher raw material costs were passed through due to better demand, and that the integrated chain created a cascading realization benefit.

For investors, the key question is margin sustainability. EBITDA margin declined to 10.5 percent from 11.3 percent, showing that cost inflation still pressed on profitability. But EBIT margin improved to 8.1 percent from 7.5 percent, and PAT margin doubled to 4.2 percent. Part of this was helped by lower finance cost in Q1 FY27 at Rs 185.7 million versus Rs 216.3 million in Q1 FY26, while depreciation was broadly stable.

Strategy and execution: integration, capacity base, and compliance spend

Bodal’s operating story remains anchored in integration across the dye value chain. The presentation describes that around 40 percent of Basic Chemicals output is expected to be captively consumed by Dye Intermediates, and around 40 percent of Dye Intermediates output is expected to be consumed by Dyestuffs. In practice, this model can dampen volatility by lowering dependence on external sourcing for key inputs and by improving cost competitiveness through internal linkages.

Scale is another structural factor. Bodal operates eight manufacturing facilities across Gujarat, Punjab, and Uttar Pradesh, supported by in house R and D labs in Vadodara. Total production capacity is stated at around 470,000 MTPA across Basic Chemicals, Dye Intermediates, Dyestuff, Liquid Dyestuff, TCCA, Caustic Soda, and benzene downstream capacity. Its product breadth is wide, with over 200 products and more than 600 customers. On end markets, textiles remain central, with the company noting that textiles constitute around 80 percent of total dyestuffs demand.

The company also positions compliance as a competitive moat in a sector under tightening environmental scrutiny. The presentation details its pollution control infrastructure, including effluent treatment plants, multiple effect evaporator plants, brine treatment, and effluent spray dryer plants. Several operating units are shown as zero discharge sites. Bodal describes the chemical industry as energy and CO2 intensive and highlights actions such as captive power at Unit 7, reuse of clean water, and salt recovery through the MEEP process.

From a market context angle, Bodal aligns itself with broad industry shifts. It cites China policy tightening and environmental norms that have eliminated smaller players, and a China plus one sourcing approach that is opening export opportunities for India. Bodal estimates its domestic and global market shares at around 13 percent and 3 percent in dyestuffs, and around 20 percent and 6 percent in dye intermediates. Export contribution has moderated to 21 percent in FY26 from 25 percent in FY25, based on standalone export data, but the company still serves 30 plus countries.

Financial track record and what to watch in FY27

FY26 marked a recovery year, and Q1 FY27 builds on that momentum. In FY26, consolidated revenue rose to Rs 20,539 million from Rs 17,567 million in FY25. EBITDA increased to Rs 2,028 million from Rs 1,707 million, while PAT rose to Rs 478 million from Rs 185 million. Margins improved as well, with PAT margin increasing to 2.3 percent from 1.1 percent.

Balance sheet and efficiency indicators also moved in a supportive direction. Net debt to equity declined to 0.67 in FY26 from 0.79 in FY25. Working capital days improved to 104.8 in FY26 from 124.9 in FY25. Returns remain moderate, with ROE at 4.1 percent and ROCE at 8.9 percent in FY26, but both improved from FY25.

The near term variables to monitor are clear from management’s own commentary. First is the persistence of raw material inflation and how much can be passed through without demand weakening. Second is whether the integration advantage continues to support realizations, especially in Dye Intermediates and Dyestuffs where the company has meaningful market presence. Third is the pace at which Saykha’s benzene downstream products add to revenue over the next few quarters. And fourth is the contribution of subsidiaries, where Turkey has improved while China and Indonesia remain subdued.

The company’s stated outlook is steady rather than aggressive. It expects improved volumes and continued pass through of higher raw material costs to help maintain revenue and margins in the near term. That framing fits a business that is scaling into a more diversified chemical portfolio while keeping a tight focus on integration, compliance, and operational execution.

Takeaways for investors: a stronger start with clear operating levers

Q1 FY27 showed that Bodal can translate a supportive demand environment into higher realizations and strong earnings growth, even with cost inflation in the system. The integrated model appears to be working as intended, with cascading benefits across divisions and a clear ability to pass through raw material moves.

The headline numbers are strong, but the quarter also signals what the next phase depends on: maintaining margin discipline in a volatile input environment, growing higher value additions such as benzene downstream products at Saykha, and lifting consistency across overseas subsidiaries. If those levers play out, Bodal’s FY26 recovery could evolve into a steadier earnings profile through FY27, supported by scale, integration, and compliance led competitiveness.